2m 2m 2m 2m 2m 2m 2m
BOUNDLESS BIO (BOLD)
NASDAQ
$2.68+$0.08 (+3.08%)
Price as of Jun 23, 2026 7:59 PM EDT- $31.4MMarket Cap
- 35.92%1-Year Change
- BiotechnologyIndustry
BOUNDLESS BIO (BOLD)
$2.68+$0.08 (+3.08%)
BOLD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.60 | ||
Change | +$1.20 (+85.71%) | ||
Open | $2.40 | ||
High | $2.75 | ||
Low | $2.25 | ||
Previous Close | $1.40 | ||
Volume | 65,510,124 | ||
30-Day Average Volume | 3,344,961 | ||
1-Week Change | 84.40% | ||
1-Month Change | 80.56% | ||
1-Year Change | 140.74% | ||
3-Year Change | -95.66% | ||
5-Year Change | -95.66% | ||
Fundamentals | |||
Shares Outstanding | 22.5M | ||
Total Assets | $141.0M | ||
Market Cap | $31.4M | ||
Enterprise Value | $14.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$13.6M | ||
Free Cash Flow | -$15.0M | ||
EBIT | -$13.6M | ||
EBITDA | -$13.3M | ||
Net Working Capital | $85.0M | ||
EPS | -$0.60 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -2 | ||
PEG | 1 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue